AxoGen, Inc. (AXGN) vs Inspire Medical Systems, Inc. (INSP)

A side-by-side comparison of AxoGen, Inc. and Inspire Medical Systems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AXGN vs INSP

growth of $100 · dividends reinvested · last 8y
AXGN -6.8% (-0.9%/yr)INSP +183.2% (+13.9%/yr)INSP compounded faster over this window
05001kStart $1002020202220242026$93$283
AXGN INSP

AXGN vs INSP: by the numbers

  • •INSP is the larger company ($1.98B vs $1.96B market cap).
  • •INSP is profitable (15.03% net margin) while AXGN runs a net loss (-13.36%).
  • •INSP grew revenue faster over the past five years (38.69% vs 13.99% CAGR).

Metrics side by side

Valuation

MetricAXGNINSP
P/E ratioN/A14.84
Forward P/E82.2157.40
P/S ratio7.792.21
P/B ratio7.632.40
EV / EBITDAN/A26.40
FCF yield0.13%5.91%

Profitability

MetricAXGNINSP
Gross margin74.56%86.13%
Operating margin-5.12%6.02%
Net margin-13.36%15.03%
ROE-13.09%16.36%
ROIC-4.68%6.33%

Growth (annualized)

MetricAXGNINSP
Revenue CAGR (5Y)13.99%38.69%
Total return CAGR (5Y)19.40%-21.38%

Frequently asked

Which has grown faster, AXGN or INSP?
Over the past five years, INSP grew revenue faster — AXGN at a 13.99% CAGR versus INSP at 38.69%.
Is AXGN or INSP more profitable?
INSP runs the higher net margin — AXGN at -13.36% versus INSP at 15.03%.
How have AXGN and INSP total returns compared?
Over the past 5 years, AXGN delivered 19.40% and INSP delivered -21.38% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.